Skip to main content
logo
BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
70.94
-0.09 (-0.13%)
At close: Mar 17, 2026, 4:00 PM EDT
70.15
-0.79 (-1.11%)
After-hours: Mar 17, 2026, 7:32 PM EDT

BridgeBio Pharma Revenue

In the year 2025, BridgeBio Pharma had annual revenue of $502.08M with 126.26% growth. BridgeBio Pharma had revenue of $154.18M in the quarter ending December 31, 2025, with 2,521.18% growth.

Revenue (ttm)
$502.08M
Revenue Growth
+126.26%
P/S Ratio
27.39
Revenue / Employee
$598,422
Employees
839
Market Cap
13.75B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025502.08M280.17M126.26%
Dec 31, 2024221.90M212.60M2,285.27%
Dec 31, 20239.30M-68.35M-88.02%
Dec 31, 202277.65M7.93M11.38%
Dec 31, 202169.72M61.47M745.14%
Dec 31, 20208.25M-32.31M-79.66%
Dec 31, 201940.56M--
Dec 31, 2018---
Dec 31, 2017---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Incyte5.14B
Jazz Pharmaceuticals4.27B
Genmab3.72B
BioMarin Pharmaceutical3.22B
Royalty Pharma2.38B
Exelixis2.32B
Madrigal Pharmaceuticals958.40M
Ionis Pharmaceuticals943.71M
Revenue Rankings

BBIO News

More News